HRMY
Harmony Biosciences Holdings, Inc.
Next earnings Aug 3, 2026 · consensus $0.94 EPS, $247M rev
Last earnings -4.1% on 2026-05-07
$35.47
▲ +3.93%$35.47▲ +11.23%
over 1Y
L $25.90EODHDH $40.51
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+3.9%
1W+2.6%
1M+13.4%
3M+24.4%
YTD-8.7%
1Y+7.0%
Buy
Conviction
Horizon
Medium (3–12mo)
Street · 17 analysts
Buy
Revenue grew 21.5% YoY.
The read
Quality fundamentals and an attractive price line up (~177% below fair value) — the rarer case where both the business and the entry look good.
Sources: SEC EDGAR (CIK 0001802665, latest 10-Q filed 2026-05-07) · EODHD · as of 6/26/2026, 6:39:30 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.